Click on one of these terms to refine your search
1 to 2 of 2 literature results
Imatinib mesylate (Gleevec) is a small-molecule inhibitor of the fusion protein Bcr-Abl, the causal agent in chronic myelogenous leukemia. Here we rep…
Authors: Risto Kerkelä, Luanda Grazette, Rinat Yacobi, Cezar Iliescu, Richard Patten, Cara Beahm, Brian Walters, Sergei Shevtsov, StĂ©phanie Pesant, Fred J Clubb,…
Source: Nature medicine. 2006 Aug
View Full TextWe report what we believe is the 1st case in the medical literature in which an intravenous thrombolytic agent was used successfully--without massive …
Authors: Morhaf Ibrahim, Cezar Iliescu, Hazim J Safi, Maximilian L Buja, David D McPherson, Francisco Fuentes
Source: Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital. 2008
View Free Full Text